Integra Lifesciences Holdings (IART) Construction in Progress (2010 - 2013)

Integra Lifesciences Holdings (IART) reported Construction in Progress of $112.1 million for Q4 2013, up 24.25% on a YoY basis from $90.2 million in Q4 2012, and up 24.25% sequentially from $90.2 million in Q4 2012.

Integra Lifesciences Holdings (IART) Construction in Progress (2010 - 2013) Analysis & Trends

Integra Lifesciences Holdings (IART) has 4 years of Construction in Progress data on file, last reported at $112.1 million in Q4 2013.

  • For the quarter ending Q4 2013, Construction in Progress rose 24.25% year-over-year to $112.1 million; the trailing twelve-month figure through Dec 2013 stood at $112.1 million (up 24.25% YoY), and the FY2013 full-year result was $112.1 million, up 24.25% from the prior year.
  • Construction in Progress grew to $112.1 million in Q4 2013, from $90.2 million in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $112.1 million in Q4 2013 to a low of $20.1 million in Q4 2010.
  • A 4-year average of $68.9 million and a median of $71.6 million in 2011 frame the typical range for Construction in Progress.
  • Across the five-year window, Construction in Progress soared 163.02% in 2011 and climbed 24.25% in 2013, its largest moves.
  • Tracing IART's Construction in Progress over 4 years: stood at $20.1 million in 2010, then soared by 163.02% to $53.0 million in 2011, then jumped by 70.38% to $90.2 million in 2012, then climbed by 24.25% to $112.1 million in 2013.
  • Business Quant data shows IART's Construction in Progress at $112.1 million in Q4 2013, $90.2 million in Q4 2012, and $53.0 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.12 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Integra Lifesciences Holdings 1.71 Bn 1.45 Bn 216.98 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2013 112.13 Mn
Dec 31, 2012 90.24 Mn
Dec 31, 2011 52.97 Mn
Dec 31, 2010 20.14 Mn